Glucose load and renal sodium handling in mild essential hypertension on different sodium intakes. 1996

J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
Department of Medicine, St George's Hospital Medical School, London, UK.

The aims of the present study were to investigate the effects of changes in sodium intake in patients with untreated mild essential hypertension on the hormonal (plasma renin activity and aldosterone) and renal tubular responses to short-term hyperinsulinemia as achieved by an oral glucose tolerance test (OGTT). Fourteen patients with essential hypertension (mean age, 46 years; average blood pressure (BP), 151/96 mm Hg) were studied. After a 1 week run-in period on their usual diet they entered a randomized double-blind crossover study of a week of low (10 mmol/day) vs a week of high (350 mmol/day) sodium intake. On the last day of each diet they underwent a standard 2-h OGTT. Blood and urines were taken hourly and segmental tubular sodium handling was assessed by the endogenous lithium clearance. The results demonstrate that the plasma insulin and glucose response to a short-term oral glucose load were not influenced significantly by the changes in dietary sodium intake. However, the glucose load was associated with marked renal sodium retention in the absence of any change in systemic BP. The reduction in renal sodium excretion was independent of circulating aldosterone but appeared to be due to an increase in renal distal tubular re-absorption.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D004039 Diet, Sodium-Restricted A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. (Dorland, 27th ed) Diet, Low-Salt,Diet, Low-Sodium,Diet, Salt-Free,Diet, Low Salt,Diet, Low Sodium,Diet, Salt Free,Diet, Sodium Restricted,Diets, Low-Salt,Diets, Low-Sodium,Diets, Salt-Free,Diets, Sodium-Restricted,Low-Salt Diet,Low-Salt Diets,Low-Sodium Diet,Low-Sodium Diets,Salt-Free Diet,Salt-Free Diets,Sodium-Restricted Diet,Sodium-Restricted Diets
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
January 1991, Journal of hypertension,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
August 1996, American journal of hypertension,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
December 1987, Journal of hypertension,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
March 1993, Annals of the New York Academy of Sciences,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
January 1985, The American journal of cardiology,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
April 1958, Circulation,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
August 1994, Journal of human hypertension,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
October 1982, Nihon Jinzo Gakkai shi,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
October 1993, Metabolism: clinical and experimental,
J Inoue, and F P Cappuccio, and G A Sagnella, and N D Markandu, and E J Folkerd, and B Sampson, and M A Miller, and A M Blackwood, and G A MacGregor
July 2013, Indian journal of endocrinology and metabolism,
Copied contents to your clipboard!